{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:19:24Z","timestamp":1761920364784,"version":"3.37.3"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T00:00:00Z","timestamp":1509926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471219","81230027"],"award-info":[{"award-number":["81471219","81230027"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Neurosci Ther"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Aims<\/jats:title><jats:p>Neuromyelitis optica spectrum disorder (<jats:styled-content style=\"fixed-case\">NMOSD<\/jats:styled-content>) is an inflammatory autoimmune disease of the central nervous system. Increasing evidence indicates that <jats:styled-content style=\"fixed-case\">NMOSD<\/jats:styled-content> is a Th2\u2010 and Th17\u2010dominant disease. <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201025, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201031, and <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201033 are three newly found Th2\u2010related cytokines, and their roles in the pathogenesis of <jats:styled-content style=\"fixed-case\">NMOSD<\/jats:styled-content> have not been studied. This study aimed to measure the serum levels of <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201025, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201031, and <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201033 in patients with <jats:styled-content style=\"fixed-case\">NMOSD<\/jats:styled-content> and evaluate their clinical implications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Serum was collected from patients with <jats:styled-content style=\"fixed-case\">NMOSD<\/jats:styled-content> (n\u00a0=\u00a048) and healthy controls (<jats:styled-content style=\"fixed-case\">HC<\/jats:styled-content>, n\u00a0=\u00a028). Serum level measurements of <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201025, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201031, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201033, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017A, and <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20106 were performed using enzyme\u2010linked immunoassay (<jats:styled-content style=\"fixed-case\">ELISA<\/jats:styled-content>) method.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The serum levels of <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201025, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201031, and <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201033 were significantly higher in patients with <jats:styled-content style=\"fixed-case\">NMOSD<\/jats:styled-content> as compared to <jats:styled-content style=\"fixed-case\">HC<\/jats:styled-content>. The serum level of <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201031 was significantly correlated with <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017A (<jats:italic>r<\/jats:italic>\u00a0=\u00a00.382,<jats:italic>P<\/jats:italic>\u00a0=\u00a00.009) in patients with <jats:styled-content style=\"fixed-case\">NMOSD<\/jats:styled-content>; the latter is a critical cytokine in the pathogenesis of <jats:styled-content style=\"fixed-case\">NMOSD<\/jats:styled-content>. The serum level of <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201033 was higher in patients with characteristic brain lesions than patients without (307\u00a0pg\/mL vs 166\u00a0pg\/mL, <jats:italic>P<\/jats:italic>\u00a0=\u00a00.028). Furthermore, the serum level of <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201033 in the acute phase of the disease was positively correlated with annualized relapse rate (<jats:italic>r<\/jats:italic>\u00a0=\u00a00.364, <jats:italic>P<\/jats:italic>\u00a0=\u00a00.04).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We found higher serum levels of <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201025, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201031, and <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201033 in patient with <jats:styled-content style=\"fixed-case\">NMOSD<\/jats:styled-content> as compared to healthy controls. The serum level of <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201033 during acute phase was associated with more past attacks in patients with <jats:styled-content style=\"fixed-case\">NMOSD<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/cns.12774","type":"journal-article","created":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T04:32:43Z","timestamp":1510029163000},"page":"64-69","source":"Crossref","is-referenced-by-count":19,"title":["Th2 axis\u2010related cytokines in patients with neuromyelitis optica spectrum disorders"],"prefix":"10.1111","volume":"24","author":[{"given":"Ying","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Neurology Ren Ji Hospital School of Medicine Shanghai Jiao Tong University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao\u2010Ying","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Neurology Ren Ji Hospital School of Medicine Shanghai Jiao Tong University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei\u2010Chun","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Neurology Ren Ji Hospital School of Medicine Shanghai Jiao Tong University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Neurology Ren Ji Hospital School of Medicine Shanghai Jiao Tong University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong\u2010Hua","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Neurology Ren Ji Hospital School of Medicine Shanghai Jiao Tong University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology Ren Ji Hospital School of Medicine Shanghai Jiao Tong University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhuang","sequence":"additional","affiliation":[{"name":"Department of Neurology Ren Ji Hospital School of Medicine Shanghai Jiao Tong University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong\u2010Gang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology Ren Ji Hospital School of Medicine Shanghai Jiao Tong University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Neurology Ren Ji Hospital School of Medicine Shanghai Jiao Tong University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7296-6670","authenticated-orcid":false,"given":"Yang\u2010Tai","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Neurology Ren Ji Hospital School of Medicine Shanghai Jiao Tong University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,11,6]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000216139.44259.74"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17551-X"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70216-8"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458510379247"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12097"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms131012970"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12558"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2015.105"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-014-0423-y"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2016.05.004"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000269"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.02.012"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2013.07.021"},{"key":"e_1_2_8_16_1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-1-4613-1241-3_6","article-title":"Structure and function of interleukin\u20104 and its receptor","volume":"80","author":"Puri RK","year":"1995","journal-title":"Cancer Treat Res"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-1241-3_7"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1084"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.10.046"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2011.07.006"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.09.015"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1308651110"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08900"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxn037"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.7.4780"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0912678107"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0801898105"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0717-1"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0718-0"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-017-8583-z"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036050"}],"container-title":["CNS Neuroscience &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcns.12774","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cns.12774","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T01:58:41Z","timestamp":1696039121000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cns.12774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,6]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1111\/cns.12774"],"URL":"https:\/\/doi.org\/10.1111\/cns.12774","archive":["Portico"],"relation":{},"ISSN":["1755-5930","1755-5949"],"issn-type":[{"type":"print","value":"1755-5930"},{"type":"electronic","value":"1755-5949"}],"subject":[],"published":{"date-parts":[[2017,11,6]]}}}